TOKYO--(BUSINESS WIRE)--In Tokyo, from May 8th to 10th, Asia's largest bio event "BIOtech 2013 in Japan" took place showing a significant growth both in the scale and the quality. Check the key figures below to see how successful the show was.
・603 exhibitors from 25 countries (UP from 490 exhibitors
from 15 countries in 2012)
・10,362 visitors from around the world
・4,845 attendees to the Keynote & Special Sessions
The Japanese bio industry gaining huge attention: Increased attendance from overseas
One of the many factors which lead BIOtech 2013 Japan to the huge
success was that the Japanese bio industry is showing signs of recovery
and further growth. Dr. Yamanaka's creation of iPS cells not only
generated the new market for iPS cell research and regenerative
medicine, also became a cause for the government to enhance its support
toward the bio/pharma-related research. Also fueled by newcomers from
other industries, business and innovation in the Japanese bio industry
Growing interests toward the Japanese market also resulted in an increased number of attendees from overseas. Due to the economic stagnation in Europe, more overseas biotech companies have chosen to exhibit at the show, setting their target to Japan. Partly because of that, the number of overseas exhibitors almost doubled from the previous show. Also, increased numbers of overseas visitors were seen having active business talks, attracted by the latest research achievements/products presented at the show.
This year, BIOtech Japan has further established its position as an international event where the Japanese/Asian bio industry and those who are targeting it all get together, as THE STATE OF ILLINOIS (exhibitor) said: "This is THE must-attend event for those targeting the Japanese market."
Highlights of BIOtech 2013 Japan (Consists of "Partnering", "Exhibition" and "Conference")
The number of appointments set through "Bio Partnering System" has almost doubled this year, especially between academics and the industry sector. As many as 176 academic presenters participated in Bio Partnering System and presented their latest research achievements at Academic Forum on-site. Many pharmaceutical companies (including the world's leading companies represented as Sponsors) actively participated in partnering, choosing BIOtech Japan as the best way to find prominent platform technologies/seeds.
Not only the number of exhibitors increased significantly from the previous years, there were some substantial changes also in the lineup of exhibitors.
Firstly, almost all the global leaders exhibited here, some of them coming back after a few years of break.
Secondly, there was increased number of overseas exhibitors, especially from Europe. There were many positive feedbacks also from first-time exhibitors, saying they could get a foothold in the Japanese market, finding agents and powerful users.
Thirdly, the show was joined by many newcomers from other industries and venture/start-up companies, especially at the NEW "Table-top exhibiting area".
Collecting a variety of exhibitors, the show further established its position as the hub of the Asian bio industry. >>Exhibitors List 2013
Keynote Session and 10 lines of Special Sessions attracted 4,845 attendees in total, covering the hot topics such as stem cells, regenerative medicine, orphan drug, antibody drug, personalized medicine, and so on. >>Full Program
Next show in May 2014
BIOtech 2014 Japan will take place from May 14 to 16, 2014 at Tokyo Big
Sight, becoming larger and more international.
More information: www.bio-t.jp/en/